Show simple item record

AuthorIannazzo, Daniela
AuthorEttari, Roberta
AuthorGiofrè, Salvatore
AuthorEid, Ali H.
AuthorBitto, Alessandra
Available date2023-08-31T19:19:09Z
Publication Date2020-10-27
Publication NameCancers
Identifierhttp://dx.doi.org/10.3390/cancers12113144
CitationIannazzo, D., Ettari, R., Giofrè, S., Eid, A. H., & Bitto, A. (2020). Recent advances in nanotherapeutics for multiple myeloma. Cancers, 12(11), 3144.
URIhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85094900259&origin=inward
URIhttp://hdl.handle.net/10576/47150
AbstractAnticancer therapies cannot be included in a one-size-fits-all scenario; it is imperative to adapt therapies to the tumor molecular profile and most importantly to develop target-specific therapeutics. Nanotherapeutics can combine molecular imaging with molecular therapy in order to provide the maximum benefit to patients in terms of disease prevention, identification, and treatment. Nanotechnology applied to therapy provides numerous advantages in diagnostics and in drug delivery, especially for those malignant cells that are diffcult to target or for drugs with poor bioavailability, such as those used for multiple myeloma (MM). This review summarizes the recent advances in the development of nanoparticle-based systems for the treatment of MM, taking into account the methods used for their functionalization, biocompatibility, and anticancer activity.
Languageen
PublisherMultidisciplinary Digital Publishing Institute (MDPI)
SubjectLiposome
Multiple myeloma
Nanotechnology
Nanotherapeutics
TitleRecent advances in nanotherapeutics for multiple myeloma
TypeArticle
Issue Number11
Volume Number12
ESSN2072-6694
dc.accessType Open Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record